Basecamp Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$693K Sell
1,643
-1,279
-44% -$510K 0.16% 67
2026
Q2
$1.06M Sell
2,922
-2
-0.1% -$685 0.2% 55
2026
Q1
$1.03M Hold
2,924
– – 0.21% 51
2025
Q4
$957K Buy
+2,924
New +$928K 0.2% 50

Other funds holding AMGN

Basecamp Wealth Advisors's AMGN Position: Q3 2026 in Review

Basecamp Wealth Advisors reduced its Amgen (AMGN) stake by 44% in Q3 2026, selling an estimated $510K and leaving 1,643 shares worth $693K. The position accounts for 0.16% of the portfolio, ranked #67.

Basecamp Wealth Advisors first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.06M in Q2 2026. 3,227 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Basecamp Wealth Advisors held 1,643 shares of Amgen worth $693K as of Q3 2026.
  • Basecamp Wealth Advisors sold 1,279 Amgen shares in Q3 2026, an estimated $510K.
  • Amgen made up 0.16% of Basecamp Wealth Advisors's portfolio in Q3 2026, its #67 holding.
  • Basecamp Wealth Advisors first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
  • Basecamp Wealth Advisors's Amgen position peaked at $1.06M in Q2 2026.
  • 3,227 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.